1. Home
  2. CLNN vs TAYD Comparison

CLNN vs TAYD Comparison

Compare CLNN & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • TAYD
  • Stock Information
  • Founded
  • CLNN 2012
  • TAYD 1955
  • Country
  • CLNN United States
  • TAYD United States
  • Employees
  • CLNN N/A
  • TAYD N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • TAYD Industrial Machinery/Components
  • Sector
  • CLNN Health Care
  • TAYD Industrials
  • Exchange
  • CLNN Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • CLNN 120.6M
  • TAYD 132.1M
  • IPO Year
  • CLNN N/A
  • TAYD N/A
  • Fundamental
  • Price
  • CLNN $8.48
  • TAYD $43.51
  • Analyst Decision
  • CLNN Strong Buy
  • TAYD
  • Analyst Count
  • CLNN 6
  • TAYD 0
  • Target Price
  • CLNN $32.67
  • TAYD N/A
  • AVG Volume (30 Days)
  • CLNN 132.8K
  • TAYD 5.9K
  • Earning Date
  • CLNN 11-13-2025
  • TAYD 01-02-2026
  • Dividend Yield
  • CLNN N/A
  • TAYD N/A
  • EPS Growth
  • CLNN N/A
  • TAYD N/A
  • EPS
  • CLNN N/A
  • TAYD 2.72
  • Revenue
  • CLNN $214,000.00
  • TAYD $44,593,219.00
  • Revenue This Year
  • CLNN N/A
  • TAYD $10.81
  • Revenue Next Year
  • CLNN $1,363.77
  • TAYD $8.37
  • P/E Ratio
  • CLNN N/A
  • TAYD $15.87
  • Revenue Growth
  • CLNN N/A
  • TAYD N/A
  • 52 Week Low
  • CLNN $2.28
  • TAYD $29.50
  • 52 Week High
  • CLNN $13.50
  • TAYD $53.73
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 47.21
  • TAYD 44.39
  • Support Level
  • CLNN $8.61
  • TAYD $43.50
  • Resistance Level
  • CLNN $10.31
  • TAYD $50.51
  • Average True Range (ATR)
  • CLNN 1.51
  • TAYD 1.80
  • MACD
  • CLNN -0.33
  • TAYD -0.06
  • Stochastic Oscillator
  • CLNN 28.22
  • TAYD 0.27

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: